Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Cancers|January 11, 2025
Challenging the Binary Classification of Endometrioid Endometrial Adenocarcinoma: The Evaluation of Grade 2 as an Independent Entity Based on Prognostic Characteristics and Recurrence PatternsAndreas Zouridis, Ammara Kashif, Ahmed Darwish, et al.Translational Cancer Research|February 12, 2026
Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort studyJacopo Conforti, Alisha Sattar, Andreas Zouridis, et al.Translational Cancer Research|December 11, 2025
Prognostic characteristics and recurrence patterns of grade 1 endometrial carcinoma: a large retrospective analysis of a tertiary centerNegin Sadeghi, Jacopo Conforti, Andreas Zouridis, et al.Journal of Clinical Medicine|October 14, 2023
Mixed Endometrial Epithelial Carcinoma: Epidemiology, Treatment and Survival Rates-A 10-Year Retrospective Cohort Study from a Single InstitutionChristina Pappa, Valentina Le Thanh, Sarah Louise Smyth, et al.Journal of Clinical Medicine|May 13, 2023
The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary CenterAndreas Zouridis, Kianoush Zarrindej, Joshua Rencher, et al.Scientific Reports|December 12, 2019
A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteinsGemma Hancock, Joshua Blight, Cesar Lopez-Camacho, et al.Epigenetics|November 4, 2017
Variability of genome-wide DNA methylation and mRNA expression profiles in reproductive and endocrine disease related tissuesNilufer Rahmioglu, Alexander W Drong, Helen Lockstone, et al.Journal of Clinical Medicine|December 30, 2025
Insights from the Pre-Molecular Era in Advanced Endometrial Cancer: Benchmarking Prognostic Indicators in High-Risk TumoursJacopo Conforti, Sabina Ioana Nistor, Negin Sadeghi, et al.Cancers|February 26, 2025
Uterine Carcinosarcoma-A Retrospective Cohort Analysis from a Tertiary Centre on Epidemiology, Management Approach, Outcomes and Survival PatternsSarah Louise Smyth, Katherine Ripullone, Andreas Zouridis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.Pageof 4